Results 101 to 110 of about 1,825 (127)

USP10 deubiquitinase: Physiological function, diseases and therapeutic target (Review). [PDF]

Int J Mol Med
Zhang L, Sun H, Wang Z, Wang Z, Mu Q, Liu Y.   +5 more
europepmc   +1 more source

Ubiquitination and deubiquitination as critical modulators of NSCLC tumorigenesis and drug resistance. [PDF]

Discov Oncol
Ramalingam PS, Afzal M, Rekha MM, Sahoo S, Pandey SN, Maji C, Goyal K, Ali H, Singh SK, Gupta G, Hussain MS, Balakrishnan P, Arumugam S.   +12 more
europepmc   +1 more source

Effect of deubiquitinases in head and neck squamous cell carcinoma (Review). [PDF]

Oncol Lett
Wang J, Wu L, Tian Z, Chen J.
europepmc   +1 more source

Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics. [PDF]

Front Pharmacol
Samareh Salavatipour M, Tavakoli S, Halimi A, Tavoosi S, Baghsheikhi AH, Talebi-Taheri A, Niloufari M, Salehi Z, Verdi J, Rahgozar S, Mosavi-Jarrahi A, Ahmadvand M.   +11 more
europepmc   +1 more source

Non-catalytic UBL2 domain directs deubiquitinase USP11 toward K48-linked polyubiquitin chains. [PDF]

J Biol Chem
Lee SR, Chen HH, Chen RH, Wu KP.
europepmc   +1 more source

USP38: an important regulatory factor in tumor malignant progression. [PDF]

Front Immunol
Li J, Zhong J, Ye J, Xiang Y, Yi Q, Zhu G, Deng S, Wang X.   +7 more
europepmc   +1 more source

Protease regulation of tumor-immune cell symbiosis. [PDF]

Trends Cancer
Pang L, Huang Y, Huang-Gao J, Chen P.
europepmc   +1 more source

Physiological roles and therapeutic implications of USP6. [PDF]

Cell Death Discov
Syed S, Painda MYK, Ghafoor D, Gu D, Wang F.   +4 more
europepmc   +1 more source